Clinical trial
A Multicenter, Prospective Cohort Study in Patients With Myasthenia Gravis in China
NCT06700616 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective Cohort Study in Patients With Myasthenia Gravis in China
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- September 26, 2024
- Completion date
- December 30, 2027
- Enrollment
- 1,199 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.